BIOSYNTIA ApS
CVR 34892970 · Private limited company (ApS) · Active · Low risk
BIOSYNTIA ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 13 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 32.9m and a net result of DKK -20.1m.
Bankruptcy risk for BIOSYNTIA ApS
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 34892970
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (13 years)
- Address
- Fruebjergvej 3
2100 København Ø - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 802k
- Employees
- 25 (2018)
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 13 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 74.2% |
| Current ratio | 444% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 611 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -14.2m | DKK -14.1m | DKK -17.8m |
| Net profit | DKK -20.1m | DKK -18.9m | DKK -29.4m |
| Equity | DKK 32.9m | DKK 52.9m | DKK 71.8m |
| Total assets | DKK 44.3m | DKK 69.2m | DKK 92.5m |
| Cash | DKK 38.2m | DKK 60.8m | – |
| Short-term debt | DKK 9.8m | DKK 8.7m | – |
| Avg. employees | 12 | 12 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 189 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 114 | ||
| 1 Jan 2023 – 31 Dec 2023 | 138 | ||
| 1 Jan 2022 – 31 Dec 2022 | 170 | ||
| 1 Jan 2021 – 31 Dec 2021 | 118 | ||
| 1 Jan 2020 – 31 Dec 2020 | 166 | ||
| 1 Jan 2019 – 31 Dec 2019 | 135 | ||
| 1 Jan 2018 – 31 Dec 2018 | 149 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 137 | ||
| 1 Jan 2015 – 31 Dec 2015 | 153 | ||
| 1 Jan 2014 – 31 Dec 2014 | 91 | ||
| 19 Dec 2012 – 31 Dec 2013 | 132 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Morten Otto Alexander Sommer | ||
| Board | Henrik Dalbøge | Current | |
| Board | Joško Bobanović | Current | |
| Board | Thomas Grotkjær | Current | |
| Board | Hans Jasper Genee | ||
| Board | Morten Otto Alexander Sommer | ||
| Board | Søren Knud Carlsen | ||
| Board | Søren Møller | ||
| Board | Michael Jean Nettersheim | ||
| Board | Sara Sande | ||
| Owner (33%) | Novo Holdings A/S | Current | |
| Owner (25%) | Sofinnova Industrial Biotech I | Current | |
| Owner (10%) | ECBF I SCSp | Current | |
| Owner (5%) | Praesidium S.C.A. SICAV-RAIF | Current | |
| Owner (10%) | Danmarks Eksport- og Investeringsfond | Current | |
| Owner (33%) | CAJAIKAS ApS | ||
| Owner (33%) | GENEE ApS | ||
| Owner (25%) | Novo Holdings A/S | ||
| Owner (25%) | Novo Holdings A/S | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (20%) | CAJAIKAS ApS | ||
| Owner (20%) | GENEE ApS | ||
| Owner (15%) | CAJAIKAS ApS | ||
| Owner (15%) | GENEE ApS | ||
| Owner (15%) | Sofinnova Industrial Biotech I | ||
| Owner (10%) | CAJAIKAS ApS | ||
| Owner (10%) | GENEE ApS | ||
| Owner (20%) | Sofinnova Industrial Biotech I | ||
| Owner (5%) | CAJAIKAS ApS | ||
| Owner (5%) | GENEE ApS | ||
| Owner (10%) | VÆKSTFONDEN | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Auditor | Selskabet af den 4. juli 2016 RVT ApS | ||
| Auditor | Datoselskabet af den 3. juli 2016 RVT P/S | ||
| Founder | CAJAIKAS ApS | Current | |
| Founder | GENEE ApS | Current |
The CEOs' other companies
Morten Otto Alexander Sommer – 11 other companies, of which 1 bankrupt
- HEED DIAGNOSTICS ApS Bankrupt 15 Apr 2016
- Clinical-Microbiomics A/S Active
- FORMBION ApS Opløst
- MANJIN ApS Active
- MICROLYTIC ApS Opløst
- Manjin Holding ApS Opløst
- NOVOZYMES A/S Active
- PALSGAARD GODS A/S Active
- SNIPR Biome ApS Active
- SNIPR Holdings ApS Active
- UNION therapeutics A/S Active
Address history (1 moves)
| Fruebjergvej 3, 2100 København Ø | |
| c/o Novo Nordisk foundation Center For Biosu, Kogle Alle 6, 2970 Hørsholm |
Employees per year
Other companies at the same address
- A DIMENSION GROUP A/S Bankrupt
- A-SYNTESE BIOTECH ApS Bankrupt
- ABSTRACTION ApS Bankrupt
- ADURA ApS Bankrupt
- AFVIKLINGSSELSKABET AF 8.2.1999 A/S Bankrupt
- ALLEGENETICS DIAGNOSTICS LABORATORY ApS Bankrupt
- ANSARI GROUP S.M.B.A. Bankrupt
- AQUALIFE A/S Bankrupt
- AREA NETWORKS ApS Bankrupt
- ASD Group Denmark ApS Bankrupt
- Afsluttet Projektselskab BLN ApS Bankrupt
- Andersen & Andersen IVS Bankrupt
- Andersentraveller ApS Bankrupt
- ApS VICTORIA STREET KOMPLEMENTAR Bankrupt
- Autocycle International ApS Bankrupt
- BB Ejendomme 2015 IVS Bankrupt
- BB Jyllands investering IVS Bankrupt
- BB Jyllands projekt IVS Bankrupt
- BINCORE GROUP A/S Bankrupt
- BINCORE INDUSTRIES A/S Bankrupt
- BLUSENSE DIAGNOSTICS APS Bankrupt
- BRUUNS INVEST ApS Bankrupt
- BRUUNS REVISION ApS Bankrupt
- BUILD ApS Bankrupt
- Baunsgaard Technologies ApS Bankrupt
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about BIOSYNTIA ApS
Has BIOSYNTIA ApS gone bankrupt?
No, BIOSYNTIA ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIOSYNTIA ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the auditor of BIOSYNTIA ApS?
BIOSYNTIA ApS most recently used Beierholm Godkendt Revisionspartnerselskab.
When was BIOSYNTIA ApS founded?
BIOSYNTIA ApS was founded on 19 December 2012.
What is the equity of BIOSYNTIA ApS?
Equity was DKK 32.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.